Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression.
Liping ChenShihao ZhuTianyuan LiuXuan ZhaoTao XiangXiao HuChen WuDongxin LinPublished in: Signal transduction and targeted therapy (2023)
Epithelial-mesenchymal transition (EMT) and proliferation play important roles in epithelial cancer formation and progression, but what molecules and how they trigger EMT is largely unknown. Here we performed spatial transcriptomic and functional analyses on samples of multistage esophageal squamous-cell carcinoma (ESCC) from mice and humans to decipher these critical issues. By investigating spatiotemporal gene expression patterns and cell-cell interactions, we demonstrated that the aberrant epithelial cell interaction via EFNB1-EPHB4 triggers EMT and cell cycle mediated by downstream SRC/ERK/AKT signaling. The aberrant epithelial cell interaction occurs within the basal layer at early precancerous lesions, which expands to the whole epithelial layer and strengthens along the cancer development and progression. Functional analysis revealed that the aberrant EFNB1-EPHB4 interaction is caused by overexpressed ΔNP63 due to TP53 mutation, the culprit in human ESCC tumorigenesis. Our results shed new light on the role of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in EMT and cell proliferation in epithelial cancer formation.
Keyphrases
- epithelial mesenchymal transition
- cell proliferation
- cell cycle
- signaling pathway
- papillary thyroid
- single cell
- gene expression
- squamous cell
- transforming growth factor
- endothelial cells
- cell therapy
- dna methylation
- pi k akt
- squamous cell carcinoma
- rna seq
- bone marrow
- lymph node metastasis
- childhood cancer
- adipose tissue
- young adults
- induced pluripotent stem cells
- high fat diet induced